ARTIDIS

medical devices

About

ARTIDIS AG is a clinical-stage health technology company based in Basel, Switzerland. It specializes in nanotechnology for cancer diagnosis and personalized treatment optimization. Founded as a spin-off from the University of Basel, ARTIDIS has developed a nanomechanical analysis platform that measures the physical properties of cells and tissues at the nanoscale using Atomic Force Microscopy (AFM). The core product quantifies cell and tissue stiffness to provide rapid and precise cancer diagnoses, assess tumor aggressiveness, and predict therapy responses. This platform integrates various clinical data into the ARTIDISNet digital platform, enabling physicians to shorten diagnostic times and design personalized cancer treatment plans. The technology is AI-powered and clinically validated, applicable to any living tissue, and designed to integrate with existing standards of care. ARTIDIS is located within Technopark Basel, fostering collaboration with leading research institutions and pharmaceutical companies.

Technologies

Outlook Google Maps WordPress.org Google Analytics Google Font API Mobile Friendly Bootstrap Framework reCAPTCHA Google Tag Manager

Keywords

nanotechnology cancer diagnostics digital health cancer treatment optimization innovation atomic force microscopy personalized therapy cancer prognosis medical equipment manufacturing b2b biomarkers treatment response medical equipment and supplies manufacturing mechanobiology clinical workflow biomechanical biomarkers microenvironment analysis biophysical properties cancer therapy personalization medical devices cancer care nanomechanical analysis biotechnology nanomechanical biomarker tissue properties biophysical tissue analysis tissue heterogeneity scalable technology clinical integration personalized medicine

Location

60c Hochbergerstrasse, Basel, Basel-Stadt, Switzerland, 4057

Related Companies

Companies in the same industry